Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHANCE: Clopidogrel plus Aspirin vs Aspirin Alone for Acute TIA or Minor Stroke
NCT00979589Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Transient Ischemic Attack (TIA) and ischemic stroke comparing Combination Clopidogrel and asprin with Asprin and placebo (2 arms). Primary endpoint: Percentage of patients with new vascular events (Any stroke: ischemic or hemorrhage) at 3 months. Started Dec 2009; status: completed.
02
Drugs
clopidogrel
03
Conditions
Transient Ischemic Attack (TIA)ischemic stroke
Beyond the preview
Go deeper on NCT00979589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979589.